» Articles » PMID: 28055103

Cancer Statistics, 2017

Overview
Publisher Wiley
Specialty Oncology
Date 2017 Jan 6
PMID 28055103
Citations 7932
Authors
Affiliations
Soon will be listed here.
Abstract

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2017, 1,688,780 new cancer cases and 600,920 cancer deaths are projected to occur in the United States. For all sites combined, the cancer incidence rate is 20% higher in men than in women, while the cancer death rate is 40% higher. However, sex disparities vary by cancer type. For example, thyroid cancer incidence rates are 3-fold higher in women than in men (21 vs 7 per 100,000 population), despite equivalent death rates (0.5 per 100,000 population), largely reflecting sex differences in the "epidemic of diagnosis." Over the past decade of available data, the overall cancer incidence rate (2004-2013) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2005-2014) declined by about 1.5% annually in both men and women. From 1991 to 2014, the overall cancer death rate dropped 25%, translating to approximately 2,143,200 fewer cancer deaths than would have been expected if death rates had remained at their peak. Although the cancer death rate was 15% higher in blacks than in whites in 2014, increasing access to care as a result of the Patient Protection and Affordable Care Act may expedite the narrowing racial gap; from 2010 to 2015, the proportion of blacks who were uninsured halved, from 21% to 11%, as it did for Hispanics (31% to 16%). Gains in coverage for traditionally underserved Americans will facilitate the broader application of existing cancer control knowledge across every segment of the population. CA Cancer J Clin 2017;67:7-30. © 2017 American Cancer Society.

Citing Articles

Hypoxia-induced MIR31HG expression promotes partial EMT and basal-like phenotype in pancreatic ductal adenocarcinoma based on data mining and experimental analyses.

Ko C, Yang P J Transl Med. 2025; 23(1):305.

PMID: 40065368 PMC: 11895263. DOI: 10.1186/s12967-025-06292-x.


Role of exercise on the reduction of cancer development: a mechanistic review from the lncRNA point of view.

Liu Q Clin Exp Med. 2025; 25(1):77.

PMID: 40063304 PMC: 11893680. DOI: 10.1007/s10238-025-01618-x.


Disruption of the sorcin‒PAX5 protein‒protein interaction induces ferroptosis by promoting the FBXL12-mediated ubiquitination of ALDH1A1 in pancreatic cancer.

Ding Y, Bai Y, Chen T, Chen S, Feng W, Ma S J Hematol Oncol. 2025; 18(1):27.

PMID: 40055736 PMC: 11887212. DOI: 10.1186/s13045-025-01680-8.


Long-term outcomes and survival rates of renal cell carcinoma patients in Erbil, Iraq: a follow-up study.

Salih F, Omar S, Hamza H, Namiq K, Ameen H, Rasul K BMC Cancer. 2025; 25(1):384.

PMID: 40033222 PMC: 11874839. DOI: 10.1186/s12885-024-13040-9.


3D bioprinting technology innovation in female reproductive system.

Chen S, Wang T, Chen J, Sui M, Wang L, Zhao X Mater Today Bio. 2025; 31:101551.

PMID: 40026632 PMC: 11870202. DOI: 10.1016/j.mtbio.2025.101551.